C20: Doxorubicin Chemoresistance Modulates GLUT Expression in Melanoma

Cancer continues to be a formidable threat to human health as the second leading cause of death in the United States. Many end-stage cancers frequently evolve into multidrug-resistant (MDR) forms, posing significant challenges in treatment design. To combat this, the Mancini Lab has recently devised a new mechanism of action known as Bystander-Assisted Immunotherapy (BAIT). […]

Begin typing your search term above and press enter to search. Press ESC to cancel.

Back To Top